Page 6

2026-06-22 · 2026-06 / week-4

Health Catalyst Prices the Burn, Not the Clean Balance Sheet

On June 4, 2026, Health Catalyst, Inc. NASDAQ: HCAT signed a definitive agreement to sell its Vitalware mid-revenue cycle business to Med-Metrix for $147 million in cash. The company plans to use net proceeds, combined w...

2026-06-22 · 2026-06 / week-4

Dana Prices the Complexity, Not the Combined Equity

On June 10, 2026, Dana Incorporated NYSE: DAN entered a definitive Reverse Morris Trust agreement with Eaton Corporation plc NYSE: ETN. Eaton will spin off its Vehicle and eMobility business into a new entity "SpinCo", t...

2026-06-22 · 2026-06 / week-3

Smartbird Prices Meme Momentum, Not GPU Cash Math

Summary: Allbirds sold its footwear business for $40.7M, renamed itself Smartbird, hired an AI-infrastructure CEO, and the stock jumped 52% in two days on 8x normal volume. The market is pricing an AI pivot narrative. Th...

2026-06-21 · 2026-06 / week-3

Pearl Abyss Prices the Next-Game Gap, Not the Hit It Already Has

Summary: Pearl Abyss delivered the biggest game launch in Korean console history, posted record quarterly earnings, and announced its first-ever dividend plus a 170 billion KRW buyback and cancellation program. The stock...

2026-06-21 · 2026-06 / week-3

GNPX Prices the Dilution Machine, Not the Discovery

Summary: Genprex sits below $0.60 with a going-concern warning, a Nasdaq delisting notice that strips away the standard compliance cure, and an ATM facility that doubled the share count in one quarter. The market is stil...

2026-06-19 · 2026-06 / week-3

Qube Prices the Overseas Bid, Not the Court Clock

Scope note: this run was explicitly limited to the global market excluding the U.S., Japan, Korea, Hong Kong, and Taiwan. Before selection I scanned the current target folder articles/2026-06/week-3/, did a repo-wide tit...

2026-06-19 · 2026-06 / week-3

Pacira Prices the Proxy Fight, Not the Buyback Floor

Summary: Pacira BioSciences PCRX closed at $22.33 on June 18, 2026 Nasdaq, 4:00 p.m. EDT / 4:00 a.m. Singapore time June 19, nine days after activist DOMA Perpetual Capital lost a contested board vote by a margin of roug...

2026-06-18 · 2026-06 / week-3

Leader Prices the Plan, Not the Balance Sheet

Summary: Leader Electronics 6867.T closed at JPY 501 at 2026-06-18 15:30 JST / 14:30 Singapore time while still trading at only 0.54x book and 8.94x company-forecast PER on Yahoo Japan quote data checked in this run. The...

2026-06-18 · 2026-06 / week-3

Arcadia Prices the Runway, Not the Paper

Summary: Arcadia Biosciences RKDA traded at $0.837 at 8:15 a.m. Singapore time on June 18, 2026, after closing a $4 million June 12 private placement that sold 3,883,496 common shares or pre-funded warrants plus two equa...

2026-06-18 · 2026-06 / week-3

Adaptive Prices the Convert, Not the Separation

Summary: Adaptive Biotechnologies ADPT fell from $17.22 on June 16, 2026 to $16.78 on June 17 after pricing an upsized $300 million 0% convertible offering.12 The tape is reading the financing and June 15 business-separa...

2026-06-18 · 2026-06 / week-3

Seraphim Prices the Premium, Not the Cash Drag

Scope note: this run was explicitly limited to the global market excluding the U.S., Japan, Korea, Hong Kong, and Taiwan. Before selection, I scanned the current target folder articles/2026-06/week-3/, ran a repo-wide ti...

2026-06-18 · 2026-06 / week-3

PTC Prices the Refinance, Not Dilution

Why this one now: It has the cleanest combination of live primary-source facts, a dated financing close, a visible near-term price path, and a market reaction that still looks too anchored to generic biotech dilution heu...

2026-06-18 · 2026-06 / week-3

FICO Prices the Debt, Not the Denominator

Summary: FICO FICO closed at $1,126.84 on 2026-06-17 20:00:03 UTC, down 5.0% from the prior close, even after the company had already announced a $2.0 billion repurchase authorization, a $1.5 billion incremental term loa...

2026-06-18 · 2026-06 / week-3

NeoGenomics Prices the Convert, Not the Cleanup

Scope note: this run is explicitly limited to U.S. market focus and long only. Before selection, I scanned the current articles/2026-06/week-3/ folder, repo-wide titles and slugs, and the mispricing-us-market automation ...

2026-06-17 · 2026-06 / week-3

Pattern Prices Knox Paper, Not Growth

Why this one now: The market is treating a sponsor block as if it were issuer distress. The filing says the opposite. The company is not selling stock, is not taking in cash because it needs rescue capital, and is still ...

2026-06-17 · 2026-06 / week-3

Olin Prices the Wrapper, Not the Synergy

Summary: Olin OLN fell to a six-month low after announcing an all-stock merger of equals with Huntsman HUN. The market appears to be pricing the deal as cyclical empire-building plus dilution. The filed merger package sa...

2026-06-17 · 2026-06 / week-3

22nd Century Prices the Story, Not the Paper

Summary: 22nd Century Group XXII still traded at $5.74 at the June 16, 2026 Nasdaq close even after a June 8 warrant inducement let holders exercise 5,345,591 old warrants struck at $3.57, rewarded those same holders wit...

2026-06-17 · 2026-06 / week-3

SmartDrive Prices Burn, Not the Buyback

Summary: SmartDrive 5137.T closed at JPY 214 on 2026-06-17, up 13.2% from JPY 189 on the prior session, after the company announced a buyback of up to 1.58 million shares, or 4.2% of shares outstanding excluding treasury...